Division of Pfizer Inc.
Latest From Pfizer Ltd.
Pfizer’s Vizimpro has been endorsed by an expert panel in India, paving the way for its potential introduction on the market, where other EGFR inhibitors including AstraZeneca’s Tagrisso have a head start.
Basilea’s Cresemba appears on course to a debut in India and partner Pfizer expects the novel antifungal to bolster its existing portfolio in the segment. Pricing of the product will be keenly watched.
GlaxoSmithKline India has carved out a specialized team with close to 300 personnel to engage with pharmacists. It is seeking to plug product availability gaps and address Rx switching at the retail level in the competitive and largely out-of-pocket Indian market.
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- Pfizer Inc.
- Senior Management
Ken Moran, Chmn. & Managing Dir.
Ian Read, Pres.
- Contact Info
Phone: (44) 1301 616161
Sandwich, CT13 9NJ
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.